What is Pharma Two B?
Pharma Two B is a biotechnology firm focused on developing innovative therapeutic solutions. Operating within the highly competitive pharmaceutical sector, the company leverages cutting-edge research and development to address unmet medical needs. Its strategic positioning within the enterprise funding sphere indicates a focus on scaling operations and advancing late-stage clinical trials, aiming to bring novel treatments to market. The company's trajectory suggests a commitment to significant growth and market impact.
How much funding has Pharma Two B raised?
Pharma Two B has raised a total of $38M across 2 funding rounds:
Series B
$8M
Private Equity
$30M
Series B (2012): $8M with participation from JK&B Capital
Private Equity (2017): $30M led by Generali Group, JVC, JK&B Capital, and Israel Biotech Fund
Key Investors in Pharma Two B
Generali Group
Generali Group, a global insurance and financial services provider, brings extensive experience in managing large-scale investments and a deep understanding of risk assessment, likely supporting Pharma Two B's long-term strategic objectives.
JVC
JVCKENWOOD Corporation, known for its consumer electronics and audio-visual solutions, may be investing in Pharma Two B to explore synergies in health technology or to diversify its portfolio into the life sciences sector.
JK&B Capital
JK&B Capital, a venture capital firm specializing in Communications, Information Technologies, and Healthcare, provides strategic financial backing and operational expertise, particularly valuable for a company navigating the complex biotech landscape.
What's next for Pharma Two B?
With the recent major strategic investment, Pharma Two B is poised for accelerated growth and the expansion of its research and development initiatives. This capital infusion is expected to fuel the progression of its drug pipeline through critical clinical phases and potentially support market entry strategies. The company's focus on enterprise-level funding signals an ambition to become a significant player in the pharmaceutical industry, likely involving further strategic partnerships and market penetration efforts.
See full Pharma Two B company page
